Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-13

Clinical Trial Update: A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke [NA]

View source ↗

Summary

A completed randomized trial evaluating the Separator 3D as part of the Penumbra System for revascularization in acute ischemic stroke due to large vessel occlu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Separator 3D (Separator 3D)

Snippet

Sponsor: Penumbra Inc. | Conditions: Acute Ischemic Stroke From Large Vessel Occlusion | NA | Status: COMPLETED | Results posted: 2018-09-13